150281-46-2

Usage

Uses

Used in Tobacco Products:
Nicotine is used as an addictive substance in tobacco products for its ability to stimulate the central nervous system and induce feelings of pleasure and reward. Its presence in these products is a significant public health concern due to its highly addictive properties.
Used in Research and Pharmaceutical Development:
Nicotine is also used in scientific research and pharmaceutical development as a model compound to study addiction and to develop treatments for nicotine dependence and smoking cessation. Understanding its effects on the brain can aid in the creation of therapies to help individuals quit smoking and reduce tobacco-related health risks.
Used in Nicotine Replacement Therapies:
In some cases, nicotine is used as a component in nicotine replacement therapies (NRTs), which are designed to help smokers gradually reduce their dependence on tobacco by providing a controlled dose of nicotine without the harmful chemicals found in tobacco smoke. This application aims to assist individuals in quitting smoking by managing withdrawal symptoms and cravings.

Upstream product

• 76304-55-7 3-(3-pyridyl)pyrrole 
• 145105-05-1 3-[1-(phenylmethyl)-3-pyrrolidinyl]pyridine 
• 72692-99-0 3-(1H-pyrrol-1-yl)pyridine 

Downstream Products

• 1003559-98-5 3-{1-[(5-benzylisoxazol-4-yl)carbonyl]pyrrolidin-3-yl}pyridine 
• 874218-24-3 tert-butyl 3-(pyridin-3-yl)pyrrolidine-1-carboxylate 
• 150281-71-3 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[3-(3-pyridinyl)-1-pyrrolidinyl]-1,8-naphthyridine-3-carboxylic acid 
• 1225218-97-2 benzyl 3-pyridin-3-ylpyrrolidine-1-carboxylate 
• 1225211-50-6 2-isopropyl-5-[(3-pyridin-3-ylpyrrolidin-1-yl)carbonyl]-1-[4-(trifluoromethoxy)phenyl]-1H-benzimidazole 
• 1234482-85-9 3-[1-(4-iodobenzoyl)pyrrolidin-3-yl]pyridine 

Relevant academic research and scientific papers

BENZIMIDAZOLE AND AZA-BENZIMIDAZOLE CARBOXAMIDES

This invention provides compounds of Formula I which are PAFR antagonists: I and the pharmaceutically acceptable salts thereof. The compounds are useful for treating PAF-mediated disorders, and can be used in methods for treating atherosclerosis and preve

BIARYL CARBOXAMIDES

This invention provides compounds of Formula (I) which are PAFR antagonists: Formula (I) and the pharmaceutically acceptable salts thereof. The compounds are useful for treating PAF-mediated disorders, and can be used in methods for treating atherosclerosis and preventing or reducing risk for atherosclerotic disease events. The compounds are also useful for treating or ameliorating pain, e.g. inflammatory pain and/or nociceptive pain, and for treating or ameliorating autoimmune and/or inflammatory diseases, among other conditions.

7-substituted quinolones and naphthyridones as antibacterial agents

7-Substituted quinolones and naphthyridones are described as antibacterial agents as well as a process for their manufacture, compositions therefor, wherein the 7-substituent is a pyrrolidine ring substituted at the 3-position by a substituted aromatic hydrocarbon or a heteroaromatic group.